Skip to main content

Cognitive and Affective Symptoms Experienced by Cancer Patients Receiving High-Dose Intravenous Interleukin 2 Therapy: An Integrative Literature Review.

Publication ,  Journal Article
Mann, TK; Dail, RB; Bailey, DE
Published in: Cancer nursing
September 2016

Alterations in cognitive/affective functioning are among the most challenging adverse effects experienced by 80% of patients with metastatic melanoma and metastatic renal cell carcinoma undergoing high-dose interleukin 2 (IL-2) therapy.The purpose of this literature review is to describe what is known about IL-2-induced cognitive/affective symptoms, their prevalence, and level of severity and synthesize findings to determine areas for future research to address symptom management challenges. This review describes the IL-2 patient experience and the pathophysiology leading to these changes.An online electronic search using PubMed was performed to identify relevant literature published between 1992 and 2015. Of the original 113 articles, information was extracted from 9 articles regarding cognitive symptoms, affective symptoms, sample size, research design, reliability, and validity.Our review suggests that the trajectories, breadth, and depth of cognitive/affective symptoms have yet to be described. Despite intervention studies designed to address the psychosocial complications of IL-2, an understanding of the level of altered cognitive/affective symptoms experienced by IL-2 patients remains unclear.Our literature review reveals a lack of standardization when assessing, reporting, and managing cognitive/affective symptoms. Patients/family members have reported cognitive/affective symptoms to be the most alarming and difficult symptoms, yet these symptoms are not adequately screened for, and patients were not informed about potential changes.Assessing patients for cognitive/affective alterations is important to reduce anxiety while improving outcomes. Education about the illness trajectory (what to expect during/after treatment) can help care partners/patients set realistic shared expectations and increase coping.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cancer nursing

DOI

EISSN

1538-9804

ISSN

0162-220X

Publication Date

September 2016

Volume

39

Issue

5

Start / End Page

349 / 357

Related Subject Headings

  • Prevalence
  • Nursing
  • Neoplasms
  • Middle Aged
  • Interleukin-2
  • Humans
  • Cognition
  • Aged
  • Affective Symptoms
  • Adult
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mann, T. K., Dail, R. B., & Bailey, D. E. (2016). Cognitive and Affective Symptoms Experienced by Cancer Patients Receiving High-Dose Intravenous Interleukin 2 Therapy: An Integrative Literature Review. Cancer Nursing, 39(5), 349–357. https://doi.org/10.1097/ncc.0000000000000317
Mann, Tara K., Robin B. Dail, and Donald E. Bailey. “Cognitive and Affective Symptoms Experienced by Cancer Patients Receiving High-Dose Intravenous Interleukin 2 Therapy: An Integrative Literature Review.Cancer Nursing 39, no. 5 (September 2016): 349–57. https://doi.org/10.1097/ncc.0000000000000317.
Mann, Tara K., et al. “Cognitive and Affective Symptoms Experienced by Cancer Patients Receiving High-Dose Intravenous Interleukin 2 Therapy: An Integrative Literature Review.Cancer Nursing, vol. 39, no. 5, Sept. 2016, pp. 349–57. Epmc, doi:10.1097/ncc.0000000000000317.

Published In

Cancer nursing

DOI

EISSN

1538-9804

ISSN

0162-220X

Publication Date

September 2016

Volume

39

Issue

5

Start / End Page

349 / 357

Related Subject Headings

  • Prevalence
  • Nursing
  • Neoplasms
  • Middle Aged
  • Interleukin-2
  • Humans
  • Cognition
  • Aged
  • Affective Symptoms
  • Adult